Navigation Links
Lilly Reports Third-Quarter 2011 Results
Date:10/20/2011

macroeconomic conditions. For additional information about the factors that affect the company's business, please see the company's latest Form 10-Q and Form 10-K filed with the U.S. Securities and Exchange Commission. The company undertakes no duty to update forward-looking statements.

Alimta® (pemetrexed, Lilly)Amyvid™ (florbetapir, Lilly)Byetta® (exenatide injection, Amylin Pharmaceuticals)Bydureon™ (exenatide for extended-release injectable suspension, Amylin Pharmaceuticals)Cialis® (tadalafil, Lilly)Cymbalta® (duloxetine hydrochloride, Lilly)Effient® (prasugrel, Lilly)Erbitux® (cetuximab, ImClone Systems, Lilly)Evista® (raloxifene hydrochloride, Lilly)Forteo® (teriparatide of recombinant DNA origin injection, Lilly)Gemzar® (gemcitabine hydrochloride, Lilly)Humalog® (insulin lispro injection of recombinant DNA origin, Lilly)Humulin® (human insulin of recombinant DNA origin, Lilly)Strattera® (atomoxetine hydrochloride, Lilly)Trajenta® (linagliptin, Boehringer Ingelheim)Trifexis™ (spinosad + milbemycin oxime, Lilly)Zyprexa® (olanzapine, Lilly)Eli Lilly and Company Employment InformationSeptember 30, 2011

December 31, 2010Worldwide Employees

38,380

38,350Eli Lilly and CompanyOperating Results  (Unaudited) – REPORTED(Dollars in millions, except per share data)Three Months EndedNine Months EndedSeptember 30September 302011

2010

% Chg.20112010

% Chg.Total Revenue

$

6,147.9

$

5,654.8

9%$

18,239.9

$

16,889.0

8%Cost of sales1,338.1987.6

35%3,746.23,134.0

20%Research and development1,280.91,219.8

5%3,665.53,446.1

6%Marketing, selling and administrative1,917.81,694.9

13%5,746.55,064.7

13%Acquired in-process research and development--

NM388.050.0

NMAsset impairments, restructuring and other special charges25.259
'/>"/>

SOURCE Eli Lilly and Company
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16

Related medicine technology :

1. Lilly Declares Fourth-Quarter 2011 Dividend
2. Lilly Announces Changes in Senior Management
3. Lilly Confirms Date and Conference Call for Third-Quarter 2011 Financial Results Announcement
4. Lilly Improves Its Environmental Footprint in Business Operations and Helps Beautify Communities
5. Eli Lilly and Company Bringing Diabetes Education Program to the Annual Legislative Conference
6. Lilly Celebrates 17th Consecutive Year as One of Working Mother 100 Best Companies
7. Lilly Health Channel Debuts on YouTube
8. Boehringer Ingelheim and Lilly to Feature Type 2 Diabetes Research in Presentations at the 47th Annual Meeting of the European Association for the Study of Diabetes
9. The American Diabetes Association and Eli Lilly and Company Encourage African Americans to Learn About Diabetes Through a Familiar Face
10. Lilly Announces Review of Data on Long-Term Raloxifene Treatment for Postmenopausal Osteoporosis Published in Current Medical Research & Opinion
11. U.S. Court of Appeals Affirms Validity of Lillys Strattera Patent
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/1/2015)... N.Y. , May 1, 2015  Misonix, ... device company that designs, manufactures and markets innovative ... neurosurgery, wound debridement, cosmetic surgery, laparoscopic surgery and ... report financial results for the third quarter fiscal ... Company has scheduled a conference call that same ...
(Date:4/30/2015)... -- Abaxis, Inc. (NasdaqGS: ABAX ), a medical ... financial results for the fourth quarter and fiscal year ... fiscal 2015 overview: , Revenues from continuing operations ... over last year,s comparable quarter, and $202.6 million for ... of $0.50 for the fourth quarter, up 194% over ...
(Date:4/30/2015)...  Thoratec Corporation (NASDAQ: THOR ), a world ... and restore failing hearts, said today it will participate ... Conference on Thursday, May 14. D. ... provide an update on the company, beginning at 10:40 ... The presentation will be available through the ...
Breaking Medicine Technology:Misonix, Inc. To Report Third Quarter Fiscal Year 2015 Financial Results On Thursday, May 7, 2015 2Abaxis Reports Financial Performance for the Fourth Quarter and Fiscal 2015 and Declares a 10% Increase in Quarterly Cash Dividend 2Abaxis Reports Financial Performance for the Fourth Quarter and Fiscal 2015 and Declares a 10% Increase in Quarterly Cash Dividend 3Abaxis Reports Financial Performance for the Fourth Quarter and Fiscal 2015 and Declares a 10% Increase in Quarterly Cash Dividend 4Abaxis Reports Financial Performance for the Fourth Quarter and Fiscal 2015 and Declares a 10% Increase in Quarterly Cash Dividend 5Abaxis Reports Financial Performance for the Fourth Quarter and Fiscal 2015 and Declares a 10% Increase in Quarterly Cash Dividend 6Abaxis Reports Financial Performance for the Fourth Quarter and Fiscal 2015 and Declares a 10% Increase in Quarterly Cash Dividend 7Abaxis Reports Financial Performance for the Fourth Quarter and Fiscal 2015 and Declares a 10% Increase in Quarterly Cash Dividend 8Abaxis Reports Financial Performance for the Fourth Quarter and Fiscal 2015 and Declares a 10% Increase in Quarterly Cash Dividend 9Abaxis Reports Financial Performance for the Fourth Quarter and Fiscal 2015 and Declares a 10% Increase in Quarterly Cash Dividend 10Abaxis Reports Financial Performance for the Fourth Quarter and Fiscal 2015 and Declares a 10% Increase in Quarterly Cash Dividend 11Abaxis Reports Financial Performance for the Fourth Quarter and Fiscal 2015 and Declares a 10% Increase in Quarterly Cash Dividend 12Abaxis Reports Financial Performance for the Fourth Quarter and Fiscal 2015 and Declares a 10% Increase in Quarterly Cash Dividend 13Abaxis Reports Financial Performance for the Fourth Quarter and Fiscal 2015 and Declares a 10% Increase in Quarterly Cash Dividend 14Abaxis Reports Financial Performance for the Fourth Quarter and Fiscal 2015 and Declares a 10% Increase in Quarterly Cash Dividend 15Abaxis Reports Financial Performance for the Fourth Quarter and Fiscal 2015 and Declares a 10% Increase in Quarterly Cash Dividend 16Abaxis Reports Financial Performance for the Fourth Quarter and Fiscal 2015 and Declares a 10% Increase in Quarterly Cash Dividend 17Abaxis Reports Financial Performance for the Fourth Quarter and Fiscal 2015 and Declares a 10% Increase in Quarterly Cash Dividend 18Abaxis Reports Financial Performance for the Fourth Quarter and Fiscal 2015 and Declares a 10% Increase in Quarterly Cash Dividend 19Abaxis Reports Financial Performance for the Fourth Quarter and Fiscal 2015 and Declares a 10% Increase in Quarterly Cash Dividend 20Abaxis Reports Financial Performance for the Fourth Quarter and Fiscal 2015 and Declares a 10% Increase in Quarterly Cash Dividend 21Abaxis Reports Financial Performance for the Fourth Quarter and Fiscal 2015 and Declares a 10% Increase in Quarterly Cash Dividend 22Abaxis Reports Financial Performance for the Fourth Quarter and Fiscal 2015 and Declares a 10% Increase in Quarterly Cash Dividend 23Abaxis Reports Financial Performance for the Fourth Quarter and Fiscal 2015 and Declares a 10% Increase in Quarterly Cash Dividend 24Thoratec Presentation At Bank Of America Merrill Lynch Healthcare Conference To Be Webcast 2
... the Millions Still Suffering from Chronic,Hepatitis B and C, ... for Disease,Control and Prevention (CDC) has reported that significant ... the United States,in the last 10 years, reflecting the ... Liver Foundation wants to,highlight these positive results, but remind ...
... tolerability profile Reduction of,testosterone concentration was maintained ... 2b trial, QUEBEC CITY, March 22, 2007 ... Japanese partner Shionogi & Co.,Ltd. today announced ... with,cetrorelix in benign prostatic hyperplasia (BPH) initiated ...
Cached Medicine Technology:The American Liver Foundation Urges Cautious Optimism about CDC,Report on Declining Acute Hepatitis Infection Rates 2The American Liver Foundation Urges Cautious Optimism about CDC,Report on Declining Acute Hepatitis Infection Rates 3AEterna Zentaris Reports Positive Results with Cetrorelix in BPH,for Japanese Phase 2a Trial 2AEterna Zentaris Reports Positive Results with Cetrorelix in BPH,for Japanese Phase 2a Trial 3AEterna Zentaris Reports Positive Results with Cetrorelix in BPH,for Japanese Phase 2a Trial 4
(Date:5/3/2015)... CA (PRWEB) May 03, 2015 NuevaCare ... MnemeTherapy® at two upcoming area seminars. The first event ... PSA Annual Regional Stroke Conference to be held at ... offered on Wednesday, May 13 during the Dementia Conference ... , “These seminars offer an excellent opportunity to ...
(Date:5/3/2015)... HealthPostures, a pioneering ergonomics company ... at the , May 5 - 7, 2015 Minnesota ... at the conference include its bestselling TaskMate sit stand ... the 6100 TaskMate Executive. Features of the 6100 TaskMate ... tray, extended platform work surface and supply holders. Weighing ...
(Date:5/2/2015)... May 02, 2015 Vancouver fencing company, QS ... provide valuable advice to prospective clients related to their questions ... to install railings around their decks and patios. While that ... that pop up once the person rolls up their sleeve ... installing a railing in finding a gate that matches it. ...
(Date:5/2/2015)... New York, NY (PRWEB) May 02, 2015 ... – when a deadly natural disaster strikes anywhere on ... ways to leverage human sympathy and compassion for their ... US-CERT (United States Computer Emergency Readiness Team) issued ... warning users “of potential email scams citing the earthquake ...
(Date:5/2/2015)... (PRWEB) May 02, 2015 On Tuesday ... City Hospital (ELCH) gathered to celebrate improvements in patient ... Valley Health Partners (RVHP), had zero acquired ventilator associated ... catheter associated infections. ELCH was also recently named a ... management team at ELCH credited the teamwork of staff ...
Breaking Medicine News(10 mins):Health News:NuevaCare Introduces MnemeTherapy® Approach to Care for Elderly Patients with Alzheimer’s, Stroke and Other Types of Neurodegenerative Conditions 2Health News:HealthPostures to Appear at the Minnesota Safety and Health Conference 2Health News:HealthPostures to Appear at the Minnesota Safety and Health Conference 3Health News:Professional Staff at QS Fencing Company Now Provides Advice on Railings and Gates 2Health News:Cyber Aftershocks from Nepal’s Earthquake Can Cripple Businesses Right Here at Home 2Health News:Cyber Aftershocks from Nepal’s Earthquake Can Cripple Businesses Right Here at Home 3Health News:Cyber Aftershocks from Nepal’s Earthquake Can Cripple Businesses Right Here at Home 4Health News:East Liverpool City Hospital Celebrates Patient Care Improvements 2
... Sept. 4 Symmetry Medical Inc.,(NYSE: SMA ... global orthopedic,device industry and other medical markets, announced ... of Specialty Surgical,Instruments (SSI) and Ultra Containers of ... and sterilization containers. About Symmetry Medical Inc. ...
... two drugs shows promise in treating a rare and therapy-resistant ... to other organs, according to a new study led by ... -- decitabine, which can turn on certain genes in cancer ... work together to cause cancer cell death. , Metastatic uveal ...
... that still kills 70,000 every year in developing countries worldwide ... nearly is always fatal when it reaches the brain. ... at Jefferson have shown how a type of bat rabies ... virus reaches the brain, when it is most lethal. They ...
... Novel treatment promotes blood vessel growth in heart muscle, ... A trial testing a genetically engineered treatment in women ... bedevil the millions of Americans with heart disease, ... and Drug Administration. , The study will enroll about ...
... Sept. 4 Martek,s life,sDHA(TM),from microalgae is ... in male,hypertriglyceridemic patients, according to a study ... Journal of Clinical Nutrition. In this study,DHA ... acid), the other omega 3 commonly found ...
... Sept. 4 In a recent New York,Times article ... turn far too quickly to drugs to solve their ... are reasonable measures people can take,first to control a ... or together, can help to lower LDLs." The Soyfoods ...
Cached Medicine News:Health News:Symmetry Medical Completes Acquisition Of Specialty Surgical Instruments 2Health News:Promising drug combination may help those with ocular melanoma that has spread 2Health News:Jefferson immunology researchers halt lethal rabies infection in brain 2Health News:Jefferson immunology researchers halt lethal rabies infection in brain 3Health News:Trial to Test Gene Therapy for Angina in Women 2Health News:Trial to Test Gene Therapy for Angina in Women 3Health News:Study Demonstrates Martek's Algal DHA Oil Improves Blood Triglyceride Lipid Levels 2Health News:Study Demonstrates Martek's Algal DHA Oil Improves Blood Triglyceride Lipid Levels 3Health News:September: Time to Try Cholesterol-Free Soyfoods 2
Leica M500 MS3 robotic stand for neuro, spine surgery and ENT. Motorized XY-movement for precise positioning of the optical axis in eight directions, inclination and tilt....
Advanced operating microscope with high-resolution apochromatic optics. Senso-servo drive to keep the microscope in perfect balance even if parts are moved or mounted elsewhere....
Advanced operating microscope with zoom and variable focus up to 500 mm....
... surgeons with brighter, crisper, magnified views of ... many minimally invasive spine procedures. It is ... of contact. The first graphical touchscreen to ... intuitive user guidance similar to that known ...
Medicine Products: